FDA orders removal of nutritional supplements over safety concerns

Focus Taiwan
Date: 2018/09/07
By: Chang Ming-hsuan and Ko Lin 

Taipei, Sept. 7 (CNA) Six different types of canned nutritional supplements produced by U.S. pharmaceutical firm Abbott Laboratories were ordered to be removed from store shelves in Taiwan due to concerns about health and safety, Taiwan’s Food and Drug Administration (FDA) said Friday.

The branded items affected were Ensure, Suplena, Nepro, Osmolite, Jevity and Osmolite HN, according to the FDA. They are all produced by the company.

Wei Jen-ting (魏任廷), an official with FDA’s Food Safety Division, said the administration made the decision after it received a total of 629 customer complaints in the first eight months of this year over these products.

An investigation later found that many of the complaints were related to rancidity and putrid tastes in the products, Wei said.    [FULL  STORY]

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.